Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients

OBJECTIVE: It is important to analyze and track Epidermal Growth Factor Receptor (EGFR) mutation status for predicting efficacy and monitoring resistance throughout EGFR-tyrosine kinase inhibitors (TKIs) treatment in non-small cell lung cancer (NSCLC) patients. The objective of this study was to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuefei, Ren, Ruixin, Ren, Shengxiang, Chen, Xiaoxia, Cai, Weijing, Zhou, Fei, Zhang, Yishi, Su, Chunxia, Zhao, Chao, Li, Jiayu, Cheng, Ningning, Zhao, Mingchuan, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145390/
https://www.ncbi.nlm.nih.gov/pubmed/25180058
http://dx.doi.org/10.1016/j.tranon.2014.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145390/
https://www.ncbi.nlm.nih.gov/pubmed/25180058
http://dx.doi.org/10.1016/j.tranon.2014.04.006

Ejemplares similares